Treatment Burden in Neovascular AMD: Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency

被引：28
|
作者：
Hussain, Rehan M. [1 ]
Hariprasad, Seenu M. [2 ]
Ciulla, Thomas A. [3 ]
机构：
[1] Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA
[2] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,MC2114, Chicago, IL 60637 USA
[3] 200 W 103rd St, Indianapolis, IN 46290 USA
来源：
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 10期
关键词：
MACULAR DEGENERATION; RANIBIZUMAB; EFFICACY; EXTEND; SAFETY; TRIAL;
D O I：
10.3928/23258160-20170928-01
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：780 / 784
页数：5
相关论文
共 50 条
  • [41] AUDIT ON ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD AT THE ROYAL VICTORIAN EYE AND EAR HOSPITAL (RVEEH)
    Abedi, Farshad
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 73 - 73
  • [42] Is there an individual re-injection frequency in patients treated with intravitreal anti-VEGF for AMD?
    Lehmann, Fabian
    Helbig, Horst
    Gamulescu, Maria Andreea
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [43] Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
    Elisabet Granstam
    Sandra Aurell
    Kersti Sjövall
    Anna Paul
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 2085 - 2093
  • [44] Switching anti-VEGF agent for wet AMD: evaluation of impact on visual acuity, treatment frequency and retinal morphology in a real-world clinical setting
    Granstam, Elisabet
    Aurell, Sandra
    Sjovall, Kersti
    Paul, Anna
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (08) : 2085 - 2093
  • [45] Anti- VEGF agents in the treatment of neovascular AMD
    Benz, Matthew S.
    Brown, David M.
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (03) : 459 - 465
  • [46] The Impact of Compartmental Exudative Volatility on Visual Acuity Outcomes in Neovascular AMD
    Ehlers, Justis P.
    Lunasco, Leina
    Yordi, Sari
    Cetin, Hasan
    Sarici, Kubra
    Le, Thuy K.
    Talcott, Katherine E.
    Zahid, Robert
    Hu, Joanne
    Meng, Xiangyi
    Kaiser, Peter K.
    Khanani, Arshad M.
    Srivastava, Sunil K.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [47] Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
    Fassnacht-Riederle, Heidi
    Becker, Matthias
    Graf, Nicole
    Michels, Stephan
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2014, 252 (11) : 1705 - 1709
  • [48] Neovascular AMD With Marked Macular Fluid and Rapid Response to Anti-VEGF Therapy
    Wood, Edward
    Chang, Jonathan S.
    Flynn, Harry W., Jr.
    Kitchens, John W.
    OPHTHALMIC SURGERY LASERS & IMAGING, 2014, 45 (02) : 175 - 178
  • [49] Effect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD
    Heidi Fassnacht-Riederle
    Matthias Becker
    Nicole Graf
    Stephan Michels
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2014, 252 : 1705 - 1709
  • [50] Anti-VEGF intervention in neovascular AMD: benefits and risks restated as natural frequencies
    Clearkin, Louis
    Ramasamy, Balasubramanian
    Wason, James
    Tiew, Stephenie
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
12345